How is melanotan 2 dosed and mixed?
Draw to
unitsmL
0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe
Concentration is the powder in the vial divided by the water. The draw is the dose divided by the concentration, in mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.
Save to Milligram
Open in Milligram shows once the calculator has a result.
Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.
Open in Milligram is off while the draw is under one unit. Check the dose and its unit.
Open in Milligram adds Melanotan II and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.
No US label sets a melanotan II dose,1 and in Dorr and colleagues' 1996 pilot trial of 3 normal men, melanotan II alternated with saline from 0.01 mg/kg, was stepped up by 0.005 mg/kg, and 0.025 mg/kg/day was named as the single dose for future phase I studies.2
The guide's example
250 mcg of Melanotan II from a 10 mg vial mixed with 2 mL is 5 units on a U-100 syringe.
Every vial at a glance. Pick a cell to draw it on the syringe.
| Vial | 1 mL of water | 2 mL of water | 3 mL of water |
|---|---|---|---|
| 10 mg96% set up8 | 10 mg/mL: 100 mcg is 1 unit, 250 mcg is 2.5 units, 500 mcg is 5 units21% set up8 | 5 mg/mL: 100 mcg is 2 units, 250 mcg is 5 units, 500 mcg is 10 units58% set up8 | 3.333 mg/mL: 100 mcg is 3 units, 250 mcg is 7.5 units, 500 mcg is 15 units14% set up8 |
Most often logged by Milligram users: 250 mcg, 29% logged.8
Vial strengths, water and syringe marks
250 mcg of Melanotan II from a 10 mg vial mixed with 2 mL is 5 units on a U-100 syringe.
58% set up 10 mg + 2 mL8
Of the people who logged melanotan II, 96% set up a 10 mg vial.8 Of the people who logged melanotan II, 58% set up a 10 mg vial with 2 mL of water, 21% with 1 mL and 14% with 3 mL.8 Of the people who logged a draw, 21% logged 250 mcg at 5 units.8 In a 2015 analysis, Breindahl and colleagues measured melanotan II vials bought from three online shops that each claimed 10 mg, and found 4.32 to 8.84 mg of melanotan II in them.3
What the trials gave
A DailyMed search returned no melanotan label,1 and the TGA states that melanotan II is a prescription-only medicine in Australia, is not approved for use as a tanning agent, and that there are currently no products containing it in the Australian Register of Therapeutic Goods.4 The published trials give weight-based doses in mg/kg, not flat mcg amounts, and the registry record gives no dose figure.5
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Dorr, 1996 | 0.01 mg/kg start, up to 0.025 or 0.03 mg/kg; subcutaneous injections daily Monday to Friday, melanotan II or saline on alternating days2 | 3 normal men | 2 consecutive weeks2 |
| Wessells, 1998 | Melanotan II against a vehicle placebo, crossover; the source gives 0.025 mg./kg as the dose with manageable side effects and names no route6 | Ten men with erectile dysfunction of no known organic cause6 | Erections recorded for 6 hours6 |
| Wessells, 2000 | 0.025 mg/kg and vehicle, each given twice by subcutaneous injection, crossover7 | Ten men with erectile dysfunction and organic risk factors7 | Monitored for 6 hours7 |
| Registry NCT07437560 | Melanotan II or matching placebo, 1:1, each with NB-UVB phototherapy; dose given only as "administered per protocol"5 | 60 adults aged 18 to 65 with stable nonsegmental vitiligo (estimated)5 | 24 weeks5 |
In the 1996 Dorr trial, two of the 3 men had increased pigmentation in the face, upper body and buttock 1 week after dosing ended, and the authors write that melanotan II has tanning activity in humans given only 5 low doses every other day by subcutaneous injection.2
Stepping and how long
In the Dorr trial, two men were stepped up in 0.005 mg/kg increments to 0.03 mg/kg and one man to 0.025 mg/kg.2 The 0.03 mg/kg dose produced Grade II somnolence and fatigue in one of the two men, and mild nausea, not requiring antiemetic treatment, was reported at most dose levels.2 No label gives a stepping schedule. Registry record NCT07437560 plans 24 weeks of melanotan II or matching placebo with NB-UVB phototherapy; it is recruiting, has posted no results, gives the dose only as "administered per protocol" and calls itself an "example trial".5
What people log
Of the people who logged a dose, 29% logged 250 mcg, 15% logged 500 mcg and 8% logged 100 mcg.8 Doses were logged in mcg by 66% and in mg by 28%.8 Of the people who logged a route, 94% logged under the skin and 6% nasal.8
Storage
No melanotan II source in the evidence gives storage conditions before or after mixing.
- Melanotan IIHalf-life, studies and regulatory status.
- Melanotan 2 calculatorMix and syringe marks for any vial.
- Mixing a peptide vialWater, steps and units.
- Copper and cosmetic peptidesThe compound group.
- GHK-Cu injection dosageA neighbouring peptide guide.
- PT-141 dosageAnother melanocortin peptide guide.
How the logged figures are counted
Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.
References
- US National Library of Medicine, DailyMed. DailyMed search for drug name melanotan, run 2026-11-17. 2026. dailymed.nlm.nih.gov
- Life Sciences (PubMed abstract). Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. 1996. pubmed.ncbi.nlm.nih.gov
- Drug Testing and Analysis (PubMed abstract). Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. 2015. pubmed.ncbi.nlm.nih.gov
- Therapeutic Goods Administration (Australia). Melanotan II tanning peptide products found to be inconsistently dosed. 2026. tga.gov.au
- ClinicalTrials.gov. Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo (NCT07437560). 2026. clinicaltrials.gov
- Journal of Urology (PubMed abstract). Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. 1998. pubmed.ncbi.nlm.nih.gov
- Urology (PubMed abstract). Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. 2000. pubmed.ncbi.nlm.nih.gov
- Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted